The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Vascular Endothelial Growth Factor Affects Dendritic Cell Maturation Through the Inhibition of Nuclear Factor-κB Activation in Hemopoietic Progenitor Cells
Abstract
Vascular endothelial growth factor (VEGF), produced by almost all tumor cells, affects the ability of hemopoietic progenitor cells (HPC) to differentiate into functional dendritic cells (DC) during the early stages of their maturation. In this study we demonstrate specific binding of VEGF to HPC. This binding was efficiently competed by placenta growth factor (PlGF), a ligand reportedly specific for the Flt-1 receptor. The number of binding sites for VEGF decreased during DC maturation in vitro associated with decreased levels of mRNA for Flt-1. VEGF significantly inhibited nuclear factor-κB (NF-κB)-dependent activation of reporter gene transcription during the first 24 h in culture. The presence of VEGF significantly decreased the specific DNA binding of NF-κB as early as 30 min after induction with TNF-α. This was followed on days 7 to 10 by decreases in the mRNA for RelB and c-Rel, two subunits of NF-κB. Blockade of NF-κB activity in HPC at early stages of differentiation with an adenovirus expressing a dominant IκB inhibitor of NF-κB reproduced the pattern of effects observed with VEGF. Thus, NF-κB plays an important role in maturation of HPCs to DC, and VEGF activation of the Flt-1 receptor is able to block the activation of NF-κB in this system. Blockade of NF-κB activation in HPCs by tumor-derived factors may therefore be a mechanism by which tumor cells can directly down-modulate the ability of the immune system to generate effective antitumor immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
Scatchard, G. (1949) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1949.tb27297.x · Cited by 19,778
Dudley, R. K. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80264-3 · Cited by 5,945
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., & Williams, L. T. (1992) · Science · doi:10.1126/science.1312256 · Cited by 2,016
Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90807-x · Cited by 1,993
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Self-citationProliferating dendritic cell progenitors in human blood.
Romani, N., Gruner, S., Brang, D., Kämpgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P. O., Steinman, R. M., & Schuler, G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.83 · Cited by 1,840
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., & Miyamoto, S. (1995) · Genes & Development · doi:10.1101/gad.9.22.2723 · Cited by 1,724
Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., & Heldin, C. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,656
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
FERRARA, N., HOUCK, K., JAKEMAN, L., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Osborn, L., Kunkel, S., & Nabel, G. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2336 · Cited by 1,621
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Barleon, B., Sozzani, S., Zhou, D., Weich, H., Mantovani, A., & Marme, D. (1996) · Blood · doi:10.1182/blood.v87.8.3336.bloodjournal8783336 · Cited by 1,356
NF-κB: A lesson in family values
Thanos, D., & Maniatis, T. (1995) · Cell · doi:10.1016/0092-8674(95)90506-5 · Cited by 1,247
Park, J. E., Chen, H. H., Winer, J., Houck, K. A., & Ferrara, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47298-5 · Cited by 1,112
Caux, C., Vanbervliet, B., Massacrier, C., Dezutter-Dambuyant, C., de Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., & Banchereau, J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.695 · Cited by 920
The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities
Clauss, M., Weich, H., Breier, G., Knies, U., Röckl, W., Waltenberger, J., & Risau, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.30.17629 · Cited by 836
Expression of relB is required for the development of thymic medulla and dendritic cells
Burkly, L., Hession, C., Ogata, L., Reilly, C., Marconl, L. A., Olson, D., Tizard, R., Gate, R., & Lo, D. (1995) · Nature · doi:10.1038/373531a0 · Cited by 780
Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α
Imbert, V., Rupec, R. A., Livolsi, A., Pahl, H. L., Traenckner, E. B.-M., Mueller-Dieckmann, C., Farahifar, D., Rossi, B., Auberger, P., Baeuerle, P. A., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80153-1 · Cited by 660
Chapter 8 Use of Recombinant Adenovirus for Metabolic Engineering of Mammalian Cells
Becker, T. C., Noel, R. J., Coats, W. S., Gómez-Foix, A. M., Alam, T., Gerard, R. D., & Newgard, C. B. (1994) · Methods in Cell Biology · doi:10.1016/s0091-679x(08)60603-2 · Cited by 569
Reporter genes: Application to the study of mammalian gene transcription
Alam, J., & Cook, J. L. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90601-5 · Cited by 470
NF-κB and Rel Proteins in Innate Immunity
(1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60618-5 · Cited by 428
Role of Vegf-Flt Receptor System in Normal and Tumor Angiogenesis
(1995) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60716-2 · Cited by 323
The v-rel oncogene encodes a κB enhancer binding protein that inhibits NF-κB function
Ballard, D. W., Walker, W. H., Doerre, S., Sista, P., Molitor, J. A., Dixon, E. P., Peffer, N. J., Hannink, M., & Greene, W. C. (1990) · Cell · doi:10.1016/0092-8674(90)90146-6 · Cited by 313
Dendritic Cells in Antitumor Immune Responses
Gabrilovich, D. I., Ciernik, I. F., & Carbone, D. P. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0139 · Cited by 289
Self-citation(1995) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60257-2 · Cited by 277
Buelens, C., Willems, F., Delvaux, A., Piérard, G., Delville, J., Velu, T., & Goldman, M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250940 · Cited by 274
Ten, R. M., Paya, C. V., Israël, N., Le Bail, O., Mattei, M. G., Virelizier, J. L., Kourilsky, P., & Israël, A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05042.x · Cited by 251
Szabolcs, P., Avigan, D., Gezelter, S., Ciocon, D., Moore, M., Steinman, R., & Young, J. (1996) · Blood · doi:10.1182/blood.v87.11.4520.bloodjournal87114520 · Cited by 216
Dendritic Cells in Antitumor Immune Responses
Gabrilovich, D. I., Nadaf, S., Corak, J., Berzofsky, J. A., & Carbone, D. P. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0140 · Cited by 213
Self-citationPatterson, C., Perrella, M. A., Endege, W. O., Yoshizumi, M., Lee, M. E., & Haber, E. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118816 · Cited by 169
Human dendritic cell differentiation pathway from CD34+ hematopoietic precursor cells
Rosenzwajg, M., Canque, B., & Gluckman, J. (1996) · Blood · doi:10.1182/blood.v87.2.535.bloodjournal872535 · Cited by 158
Human renal-cell carcinoma tissue contains dendritic cells
Thurnher, M., Radmayr, C., Ramoner, R. E., Ebner, S., Böck, G., Klocker, H., Romani, N., & Bartsch, G. H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960927)68:1<1::aid-ijc1>3.0.co;2-v · Cited by 149
Carrasco, D. R., Ryseck, R.-P., & Bravo, R. (1993) · Development · doi:10.1242/dev.118.4.1221 · Cited by 142
Sica, A., Tan, T., Rice, N. R., Kretzschmar, M., Ghosh, P., & Young, H. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1740 · Cited by 127
Granelli‐Piperno, A., Pope, M., Inaba, K., & Steinman, R. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.10944 · Cited by 123
Singh, S., Darnay, B. G., & Aggarwal, B. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31049 · Cited by 122
Transcriptional Regulation of NF-κB2: Evidence for κB-Mediated Positive and Negative Autoregulation
Liptay, S., Schmid, R. M., Nabel, E. G., & Nabel, G. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.12.7695-7703.1994 · Cited by 115
Takeshita, S., Gage, J. R., Kishimoto, T., Vredevoe, D. L., & Martı́nez-Maza, O. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2591 · Cited by 98
Tas, M. P. R., Simons, P. J., Balm, F. J. M., & Drexhage, H. A. (1993) · Cancer Immunology Immunotherapy · doi:10.1007/bf01754410 · Cited by 71
Boehmelt, G., Madruga, J., Ddrfler, P., Briegel, K. J., Schwarz, H., Enrietto, P. J., & Zenke, M. (1995) · Cell · doi:10.1016/0092-8674(95)90417-4 · Cited by 61
Maio, J. J., & Brown, F. L. (1988) · Journal of Virology · doi:10.1128/jvi.62.4.1398-1407.1988 · Cited by 43
Feuillard, J., Körner, M., Israël, A., Vassy, J., & Raphaël, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261102 · Cited by 43
Clarke, C. J. P., Taylor, D., Hales, A., Chernajovsky, Y., Sugamura, K., Feldmann, M., & Foxwell, B. M. J. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251037 · Cited by 39
Broxmeyer, H. E., Cooper, S. H., Li, Z.-H., Lu, L., Sarris, A. H., Wang, M.-H., Chang, M., Donner, D. B., & Leonard, E. J. (1996) · Annals of Hematology · doi:10.1007/s002770050192 · Cited by 31
Kerrebijn, J. D. F., Simons, P. J., Tas, M., Balm, A. J. M., & Drexhage, H. A. (1995) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/bf00167311 · Cited by 9
Cited by
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
Socinski, M. A., Jotte, R. M., Cappuzzo, F., Orlandi, F., Stroyakovskiy, D., Nogami, N., Rodríguez-Abreu, D., Moro-Sibilot, D., Thomas, C. A., Barlesi, F., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716948 · Cited by 3,733
Top 10 Challenges in Cancer Immunotherapy
Hegde, P. S., & Chen, D. S. (2020) · Immunity · doi:10.1016/j.immuni.2019.12.011 · Cited by 2,238
Mao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290
Vascular Endothelial Growth Factor and Angiogenesis
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., & De Bruijn, E. A. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.3 · Cited by 1,824
Toward personalized treatment approaches for non-small-cell lung cancer
Wang, M., Herbst, R. S., & Boshoff, C. (2021) · Nature Medicine · doi:10.1038/s41591-021-01450-2 · Cited by 1,093
Metadata
- Authors
- Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L., Carbone, D. P., & Gabrilovich, D. I.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-02-01
- Volume
- 160
- Issue
- 3
- Pages
- 1224-1232
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W4313333674
- Cited by
- 481
- References
- 46
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.